12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Lantern Pharma (NASDAQ:LTRN) shares rose 14.3% to $7.04 during Friday’s after-market session. The company’s market cap stands…
Vaxart Announces Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers; Long-Term Goal Is To Provide Protection To Infants Through Passive Antibody Transfer
Antibody rise observed in lactating mothers and in their breast milk Long-term goal is to provide protection to infants through passive antibody transferSOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE)
Vaxart Announces Publication In Vaccines Of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal And Systemic Immunogenicity And Reduce Viral Shedding After SARS-CoV-2 Challenge
— Data served as foundation for current vaccine candidate for planned Phase 2 research— Vaxart vaccine candidates elicited strong antigen-specific serum IgG and IgA with neutralizing activity
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results.
AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion.
AMD shares dipped 3.8% to $165.49 on Wednesday.
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares moved upwards by 36.0% to $0.21 during Wednesday’s regular session. The market value…
Vaxart Receives $9.27M BARDA Project NextGen Award To Prepare For Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
- 10,000-subject Phase 2b study would evaluate Vaxart's next generation oral pill XBB COVID-19 vaccine against an approved mRNA vaccine comparator - - Project NextGen is a $5 billion initiative by the U.S.
What’s Going On With Vaxart Stock Today?
Vaxart shares are trading higher by around 8% Wednesday afternoon. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Vaxart (NASDAQ:VXRT) shares rose 37.5% to $0.77 during Tuesday’s regular session. The company’s market cap stands at…
What’s Going On With Vaxart (VXRT) Stock?
Vaxart shares are trading higher by 17.8% Tuesday morning amid multiple news items. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services.
UPDATE: On Jan. 12, Vaxart Announced Co Will Receive An Award To Support Clinical Trial Planning Activities For A Phase 2b Clinical Trial That Would Compare The Co’s XBB Vaccine Candidate To An mRNA Comparator; Total Contract Value Of $9,271,193.00
On January 12, 2024, Vaxart, Inc. (the "Company") was awarded a contract (the "ASPR Contract") by the U.S. Government through the Department of Health and Human Services, Office of the Administration for Strategic